Your browser doesn't support javascript.
loading
A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity.
Colon-Moran, Winston; Baer, Alan; Lamture, Gauri; Stapleton, Jack T; Fischer, Joseph W; Bhattarai, Nirjal.
Afiliação
  • Colon-Moran W; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Baer A; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Lamture G; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Stapleton JT; Adicet Bio, Inc., Menlo Park, CA, USA.
  • Fischer JW; Research Service, Iowa City Veterans Affairs Medical Center, Iowa City, IA, USA.
  • Bhattarai N; Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, IA, USA.
Gene Ther ; 29(10-11): 616-623, 2022 11.
Article em En | MEDLINE | ID: mdl-34759330
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article